abstract |
FIELD: immunology.SUBSTANCE: present invention relates to immunology. Antibodies binding with human alpha-synuclein, as well as conjugate of antibody with shuttle module for blood-brain barrier are offered. Besides, a pharmaceutical composition and application of antibodies are considered.EFFECT: present invention can find further application in therapy of various conditions, in particular synucleinopathy and Parkinson's disease.8 cl, 16 dwg, 9 tbl, 14 ex |